Halozyme Therapeutics reported $3.32M in Trade Creditors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 7.72M 1.34M
Agios Pharmaceuticals AGIO:US $ 10.31M 2.65M
Alnylam Pharmaceuticals ALNY:US $ 40.05M 13.03M
Amarin AMRN:US $ 72.42M 68.84M
Amgen AMGN:US $ 1171M 106M
Aptinyx Inc APTX:US $ 3.12M 2.68M
Arena Pharmaceuticals ARNA:US $ 6.94M 3.15M
Baxter International BAX:US 999M 6M
Eli Lilly And LLY:US $ 1566.8M 31M
Esperion Therapeutics ESPR:US $ 20.74M 8.61M
Halozyme Therapeutics HALO:US $ 3.32M 1.24M
Intra Cellular Therapies ITCI:US $ 12.03M 3.91M
Intrexon XON:US $ 3.62M 1.31M
JAZZ PHA JAZZ:US $ 63.82M 1.01M
Mannkind MNKD:US $ 9.53M 2.04M
Minerva Neurosciences NERV:US $ 1.2M 0.39M
Nektar Therapeutics NKTR:US $ 23.66M 3.96M
Peregrine Pharmaceuticals PPHM:US $ 9.61M 0.35M
Rigel Pharmaceuticals RIGL:US $ 3.14M 1.46M